PhRMA Says More than Half of Pharmacy and Provider Profits on Brand Drug Sales Come Through 340B

PhRMA says 52% of U.S. pharmacies and health care providers profits' from reimbursement for administering brand-name prescription drugs now comes through participation in the 340B program. The AHA calls the finding an example of drug companies deflecting attention away from the high prices they set.

More than half (52%) of the $81 billion that U.S. pharmacies and health care providers collected in 2020 in reimbursement from payers for brand-name prescription drugs came through pharmacy and provider participation in the 340B program, up from 14% of

Read More »

Citing Omicron Wave, 340B Coalition Weighs Making Winter Conference a Hybrid Live/Virtual Event

Citing concerns about COVID-19's Omicron variant, the 340B Coalition is considering turning its Jan. 31–Feb. 2 in-person winter conference into a hybrid in-person/virtual event.

The 340B Coalition said yesterday it is “actively exploring the potential for a hybrid [winter 2022] conference that would allow attendance in-person or virtually for those that cannot attend in-person.”

The coalition, composed of 13 groups that represent 340B covered

Read More »

More Than 850 Hospitals Ask Feds to Appeal Judge’s 340B Contract Pharmacy Ruling

850+ hospitals in the 340B program sent the HHS secretary a letter yesterday asking the government to appeal a judge’s 340B contract pharmacy ruling.

Just over 850 hospitals in the 340B program asked the federal government yesterday to appeal a judge’s Nov. 5 ruling that halted enforcement actions against two drug companies that deny 340B pricing when hospitals and others use contract pharmacies. They

Read More »

Provider Groups Pan Lilly’s 340B Contract Pharmacy Policy Change

Groups representing health care providers have panned Lilly's recent 340B contract pharmacy policy change.

Groups representing 340B health centers, Ryan White clinics, and hospitals panned drug manufacturer Lilly’s recent decision to amend its prohibition on 340B pricing when providers use contract pharmacies to dispense drugs to patients.

Lilly told drug wholesaler AmerisourceBergen on

Read More »

HIV Care Providers Sound Alarm About Threats to 340B Savings

HIV care professionals are raising an alarm about threats to 340B savings and their consequences for patient care.

HIV care professionals are warning the public that threats to 340B drug discount savings “will compromise access to affordable care, treatment, and prevention services for underserved people with and at risk for HIV.”

The American Academy of HIV Medicine, the

Read More »

AHA Criticizes JAMA Study of What Hospitals Charge for Clinician-Administered Drugs

The AHA says a JAMA study on what hospitals charge insurers for clinician-administered drugs lacks context.

The American Hospital Association (AHA) has pushed back on a JAMA Internal Medicine study suggesting that leading acute care facilities that are 340B covered entities have wide variations in how much they charge insurers for clinician-administered drugs.

That study,

Read More »

340B Coalition Says It Will Hold 2022 Winter Conference in-Person

The 340B Coalition is holding its 2022 winter conference in person in San Diego.

The 340B Coalition announced Tuesday that its annual winter conference will be held in person Jan. 31 to Feb. 2, 2022, in San Diego. Its last, pre-pandemic in-person conference was Feb. 10-12, 2020, also in San Diego.

Apexus, the 340B

Read More »

With Delta Variant Persisting, Health Care Groups Struggle with Conference Planning

Many health care organizations are reconsidering plans for in-person conferences as a result of the Delta variant. The 340B Coalition is polling potential attendees regarding their preferences for the its winter conference in late January.

After an initial burst of optimism earlier this year, some health care organizations are having second thoughts about large in-person events for the remainder of 2021 and the start of the new year.  However, some groups including the 340B Coalition

Read More »

Hospitals Urge CMS To Abandon Medicare Part B Cuts While PhRMA Presses For More Action

Hospital trade groups have lodged strong objections to CMS's proposal to maintain deep Medicare Part B reimbursement cuts, while PhRMA is suggesting even further 340B reforms.

Hospital trade groups are lodging strong objections to maintaining steep cuts in Medicare Part B drug reimbursement as part of the Fiscal Year 2022 final rule for the hospital outpatient prospective payment system (OPPS), while the trade group for brand

Read More »

340B Hospitals Provide Almost $68 Billion Annually in Community Benefits, AHA Says

340B hospitals provided $67.9 billion in total community benefits in 2018, AHA reported yesterday.

Hospitals participating in the 340B program provided $67.9 billion in total benefits to their communities in 2018, the American Hospital Association (AHA) reported yesterday. Community benefits represented 13.7% of total 340B hospital expenses, the group said.

AHA broke out

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report